Selected research
Industry Growth & Trends
Global Prilocaine Industry Growth and Trends Forecast to 2032
Market perspective
The global Prilocaine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Prilocaine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Prilocaine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Prilocaine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Prilocaine include Active Biopharma Corp, Anant Pharmaceuticals, B. Braun, ANXIN PHARMACEUTICAL, Yeasen Biotechnology, Nanjing HuaNuo Bio-Pharmaceutical Technology, Beijing Vokai Biotechnology and Haisco Pharmaceutical Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Prilocaine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Prilocaine market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Prilocaine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Prilocaine.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Prilocaine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Prilocaine Market by Company
Active Biopharma Corp
Anant Pharmaceuticals
B. Braun
ANXIN PHARMACEUTICAL
Yeasen Biotechnology
Nanjing HuaNuo Bio-Pharmaceutical Technology
Beijing Vokai Biotechnology
Haisco Pharmaceutical Group
Prilocaine Segment by Type
3% Solution
2% Solution
1% Solution
Other
Prilocaine Segment by Application
Public Hospital
Private Hospital
Prilocaine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prilocaine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Prilocaine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prilocaine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prilocaine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Prilocaine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 3% Solution
- 2% Solution
- 1% Solution
- Other
Applications
- Public Hospital
- Private Hospital
Companies covered
- Active Biopharma Corp
- Anant Pharmaceuticals
- B. Braun
- ANXIN PHARMACEUTICAL
- Yeasen Biotechnology
- Nanjing HuaNuo Bio-Pharmaceutical Technology
- Beijing Vokai Biotechnology
- Haisco Pharmaceutical Group
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Prilocaine Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Prilocaine Sales Estimates and Forecasts (2021-2032)
- 1.3 Prilocaine Market by Type
- 1.3.1 3% Solution
- 1.3.2 2% Solution
- 1.3.3 1% Solution
- 1.3.4 Other
- 1.4 Global Prilocaine Market Size by Type
- 1.4.1 Global Prilocaine Market Size Overview by Type (2021-2032)
- 1.4.2 Global Prilocaine Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Prilocaine Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Prilocaine Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Prilocaine Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Prilocaine Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Prilocaine Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Prilocaine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Prilocaine Industry Trends
- 2.2 Prilocaine Industry Drivers
- 2.3 Prilocaine Industry Opportunities and Challenges
- 2.4 Prilocaine Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Prilocaine Revenue (2021-2026)
- 3.2 Global Top Players by Prilocaine Sales (2021-2026)
- 3.3 Global Top Players by Prilocaine Price (2021-2026)
- 3.4 Global Prilocaine Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Prilocaine Major Company Production Sites & Headquarters
- 3.6 Global Prilocaine Company, Product Type & Application
- 3.7 Global Prilocaine Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Prilocaine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Prilocaine Players Market Share by Revenue in 2025
- 3.8.3 2025 Prilocaine Tier 1, Tier 2, and Tier 3
4 Prilocaine Regional Status and Outlook
- 4.1 Global Prilocaine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Prilocaine Historic Market Size by Region
- 4.2.1 Global Prilocaine Sales in Volume by Region (2021-2026)
- 4.2.2 Global Prilocaine Sales in Value by Region (2021-2026)
- 4.2.3 Global Prilocaine Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Prilocaine Forecasted Market Size by Region
- 4.3.1 Global Prilocaine Sales in Volume by Region (2027-2032)
- 4.3.2 Global Prilocaine Sales in Value by Region (2027-2032)
- 4.3.3 Global Prilocaine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Prilocaine by Application
- 5.1 Prilocaine Market by Application
- 5.1.1 Public Hospital
- 5.1.2 Private Hospital
- 5.2 Global Prilocaine Market Size by Application
- 5.2.1 Global Prilocaine Market Size Overview by Application (2021-2032)
- 5.2.2 Global Prilocaine Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Prilocaine Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Prilocaine Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Prilocaine Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Prilocaine Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Prilocaine Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Prilocaine Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Active Biopharma Corp
- 6.1.1 Active Biopharma Corp Company Information
- 6.1.2 Active Biopharma Corp Business Overview
- 6.1.3 Active Biopharma Corp Prilocaine Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Active Biopharma Corp Prilocaine Product Portfolio
- 6.1.5 Active Biopharma Corp Recent Developments
- 6.2 Anant Pharmaceuticals
- 6.2.1 Anant Pharmaceuticals Company Information
- 6.2.2 Anant Pharmaceuticals Business Overview
- 6.2.3 Anant Pharmaceuticals Prilocaine Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Anant Pharmaceuticals Prilocaine Product Portfolio
- 6.2.5 Anant Pharmaceuticals Recent Developments
- 6.3 B. Braun
- 6.3.1 B. Braun Company Information
- 6.3.2 B. Braun Business Overview
- 6.3.3 B. Braun Prilocaine Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 B. Braun Prilocaine Product Portfolio
- 6.3.5 B. Braun Recent Developments
- 6.4 ANXIN PHARMACEUTICAL
- 6.4.1 ANXIN PHARMACEUTICAL Company Information
- 6.4.2 ANXIN PHARMACEUTICAL Business Overview
- 6.4.3 ANXIN PHARMACEUTICAL Prilocaine Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 ANXIN PHARMACEUTICAL Prilocaine Product Portfolio
- 6.4.5 ANXIN PHARMACEUTICAL Recent Developments
- 6.5 Yeasen Biotechnology
- 6.5.1 Yeasen Biotechnology Company Information
- 6.5.2 Yeasen Biotechnology Business Overview
- 6.5.3 Yeasen Biotechnology Prilocaine Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Yeasen Biotechnology Prilocaine Product Portfolio
- 6.5.5 Yeasen Biotechnology Recent Developments
- 6.6 Nanjing HuaNuo Bio-Pharmaceutical Technology
- 6.6.1 Nanjing HuaNuo Bio-Pharmaceutical Technology Company Information
- 6.6.2 Nanjing HuaNuo Bio-Pharmaceutical Technology Business Overview
- 6.6.3 Nanjing HuaNuo Bio-Pharmaceutical Technology Prilocaine Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Nanjing HuaNuo Bio-Pharmaceutical Technology Prilocaine Product Portfolio
- 6.6.5 Nanjing HuaNuo Bio-Pharmaceutical Technology Recent Developments
- 6.7 Beijing Vokai Biotechnology
- 6.7.1 Beijing Vokai Biotechnology Company Information
- 6.7.2 Beijing Vokai Biotechnology Business Overview
- 6.7.3 Beijing Vokai Biotechnology Prilocaine Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Beijing Vokai Biotechnology Prilocaine Product Portfolio
- 6.7.5 Beijing Vokai Biotechnology Recent Developments
- 6.8 Haisco Pharmaceutical Group
- 6.8.1 Haisco Pharmaceutical Group Company Information
- 6.8.2 Haisco Pharmaceutical Group Business Overview
- 6.8.3 Haisco Pharmaceutical Group Prilocaine Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Haisco Pharmaceutical Group Prilocaine Product Portfolio
- 6.8.5 Haisco Pharmaceutical Group Recent Developments
7 North America by Country
- 7.1 North America Prilocaine Sales by Country
- 7.1.1 North America Prilocaine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Prilocaine Sales by Country (2021-2026)
- 7.1.3 North America Prilocaine Sales Forecast by Country (2027-2032)
- 7.2 North America Prilocaine Market Size by Country
- 7.2.1 North America Prilocaine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Prilocaine Market Size by Country (2021-2026)
- 7.2.3 North America Prilocaine Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Prilocaine Sales by Country
- 8.1.1 Europe Prilocaine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Prilocaine Sales by Country (2021-2026)
- 8.1.3 Europe Prilocaine Sales Forecast by Country (2027-2032)
- 8.2 Europe Prilocaine Market Size by Country
- 8.2.1 Europe Prilocaine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Prilocaine Market Size by Country (2021-2026)
- 8.2.3 Europe Prilocaine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Prilocaine Sales by Country
- 9.1.1 Asia-Pacific Prilocaine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Prilocaine Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Prilocaine Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Prilocaine Market Size by Country
- 9.2.1 Asia-Pacific Prilocaine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Prilocaine Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Prilocaine Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Prilocaine Sales by Country
- 10.1.1 South America Prilocaine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Prilocaine Sales by Country (2021-2026)
- 10.1.3 South America Prilocaine Sales Forecast by Country (2027-2032)
- 10.2 South America Prilocaine Market Size by Country
- 10.2.1 South America Prilocaine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Prilocaine Market Size by Country (2021-2026)
- 10.2.3 South America Prilocaine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Prilocaine Sales by Country
- 11.1.1 Middle East and Africa Prilocaine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Prilocaine Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Prilocaine Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Prilocaine Market Size by Country
- 11.2.1 Middle East and Africa Prilocaine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Prilocaine Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Prilocaine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Prilocaine Value Chain Analysis
- 12.1.1 Prilocaine Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Prilocaine Production Mode & Process
- 12.2 Prilocaine Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Prilocaine Distributors
- 12.2.3 Prilocaine Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst